Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease.

Agarwal, Khushboo; Rajan, Remya; Paul, Jinson; Cherian, Kripa Elizabeth; Kapoor, Nitin; Paul, Thomas V

Agarwal, Khushboo; Rajan, Remya; Paul, Jinson; Cherian, Kripa Elizabeth; Kapoor, Nitin; Paul, Thomas V.

Afiliación

Agarwal K; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Rajan R; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Paul J; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Cherian KE; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Kapoor N; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Paul TV; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

AACE Clin Case Rep ; 8(2): 54-57, 2022.

Article en En | MEDLINE | ID: mdl-35415233

Palabras clave

CED, Camurati-Engelmann disease; Camurati-Engelmann disease; TGF, transforming growth factor; TGFß1; bisphosphonates; losartan; progressive diaphyseal dysplasia; steroids

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: AACE Clin Case Rep Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google